A detailed history of Bellevue Asset Management, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Bellevue Asset Management, LLC holds 200 shares of XBI stock, worth $18,918. This represents 0.01% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$18,918
Previous $18,000 5.56%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

SELL
$81.07 - $115.44 $12,160 - $17,316
-150 Reduced 42.86%
200 $18,000
Q3 2021

Nov 05, 2021

SELL
$118.69 - $138.49 $6,290 - $7,339
-53 Reduced 13.15%
350 $44,000
Q2 2021

Aug 09, 2021

SELL
$122.48 - $139.69 $24,496 - $27,938
-200 Reduced 33.17%
403 $55,000
Q4 2019

Feb 13, 2020

BUY
$74.65 - $98.46 $45,013 - $59,371
603 New
603 $57,000

Others Institutions Holding XBI

About SPDR SER TR SPDR S&P BIOTECH E


  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Bellevue Asset Management, LLC Portfolio

Follow Bellevue Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Asset Management, LLC with notifications on news.